Report Detail
Global Patent Drug Market Growth (Status and Outlook) 2022-2028
- RnM4498127 |
- 13 December, 2022 |
- Global |
- 124 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
A patent medicine is typically protected and advertised by a trademark and trade name (and sometimes a patent) and claimed to be effective against minor disorders and symptoms.
The global market for Patent Drug is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Patent Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Patent Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Patent Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Patent Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Patent Drug players cover Johnson & Johnson, Novartis, Roche, AbbVie and Merck & Co., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Patent Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Patent Drug market, with both quantitative and qualitative data, to help readers understand how the Patent Drug market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Patent Drug market and forecasts the market size by Type (Oral, Injection and Other), by Application (Hospital and Retail Pharmacy.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Oral
Injection
Other
Segmentation by application
Hospital
Retail Pharmacy
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Johnson & Johnson
Novartis
Roche
AbbVie
Merck & Co.
Bristol Myers Squibb
GlaxoSmithKline
Pfizer
Sanofi
Takeda
AstraZeneca
Bayer
Eli Lilly & Co.
Gilead Sciences
Amgen
Novo Nordisk
Teva
Boehringer Ingelheim
Biogen
Astellas
Chapter Introduction
Chapter 1: Scope of Patent Drug, Research Methodology, etc.
Chapter 2: Executive Summary, global Patent Drug market size and CAGR, Patent Drug market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Patent Drug revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Patent Drug revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Patent Drug market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Johnson & Johnson, Novartis, Roche, AbbVie, Merck & Co., Bristol Myers Squibb, GlaxoSmithKline, Pfizer and Sanofi, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Patent Drug Market Size 2017-2028
- 2.1.2 Patent Drug Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 Patent Drug Segment by Type
- 2.2.1 Oral
- 2.2.2 Injection
- 2.2.3 Other
- 2.3 Patent Drug Market Size by Type
- 2.3.1 Patent Drug Market Size CAGR by Type (2017 VS 2022 VS 2028)
- 2.3.2 Global Patent Drug Market Size Market Share by Type (2017-2022)
- 2.4 Patent Drug Segment by Application
- 2.4.1 Hospital
- 2.4.2 Retail Pharmacy
- 2.5 Patent Drug Market Size by Application
- 2.5.1 Patent Drug Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global Patent Drug Market Size Market Share by Application (2017-2022)
3 Patent Drug Market Size by Player
- 3.1 Patent Drug Market Size Market Share by Players
- 3.1.1 Global Patent Drug Revenue by Players (2020-2022)
- 3.1.2 Global Patent Drug Revenue Market Share by Players (2020-2022)
- 3.2 Global Patent Drug Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Patent Drug by Regions
- 4.1 Patent Drug Market Size by Regions (2017-2022)
- 4.2 Americas Patent Drug Market Size Growth (2017-2022)
- 4.3 APAC Patent Drug Market Size Growth (2017-2022)
- 4.4 Europe Patent Drug Market Size Growth (2017-2022)
- 4.5 Middle East & Africa Patent Drug Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas Patent Drug Market Size by Country (2017-2022)
- 5.2 Americas Patent Drug Market Size by Type (2017-2022)
- 5.3 Americas Patent Drug Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Patent Drug Market Size by Region (2017-2022)
- 6.2 APAC Patent Drug Market Size by Type (2017-2022)
- 6.3 APAC Patent Drug Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Patent Drug by Country (2017-2022)
- 7.2 Europe Patent Drug Market Size by Type (2017-2022)
- 7.3 Europe Patent Drug Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Patent Drug by Region (2017-2022)
- 8.2 Middle East & Africa Patent Drug Market Size by Type (2017-2022)
- 8.3 Middle East & Africa Patent Drug Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Patent Drug Market Forecast
- 10.1 Global Patent Drug Forecast by Regions (2023-2028)
- 10.1.1 Global Patent Drug Forecast by Regions (2023-2028)
- 10.1.2 Americas Patent Drug Forecast
- 10.1.3 APAC Patent Drug Forecast
- 10.1.4 Europe Patent Drug Forecast
- 10.1.5 Middle East & Africa Patent Drug Forecast
- 10.2 Americas Patent Drug Forecast by Country (2023-2028)
- 10.2.1 United States Patent Drug Market Forecast
- 10.2.2 Canada Patent Drug Market Forecast
- 10.2.3 Mexico Patent Drug Market Forecast
- 10.2.4 Brazil Patent Drug Market Forecast
- 10.3 APAC Patent Drug Forecast by Region (2023-2028)
- 10.3.1 China Patent Drug Market Forecast
- 10.3.2 Japan Patent Drug Market Forecast
- 10.3.3 Korea Patent Drug Market Forecast
- 10.3.4 Southeast Asia Patent Drug Market Forecast
- 10.3.5 India Patent Drug Market Forecast
- 10.3.6 Australia Patent Drug Market Forecast
- 10.4 Europe Patent Drug Forecast by Country (2023-2028)
- 10.4.1 Germany Patent Drug Market Forecast
- 10.4.2 France Patent Drug Market Forecast
- 10.4.3 UK Patent Drug Market Forecast
- 10.4.4 Italy Patent Drug Market Forecast
- 10.4.5 Russia Patent Drug Market Forecast
- 10.5 Middle East & Africa Patent Drug Forecast by Region (2023-2028)
- 10.5.1 Egypt Patent Drug Market Forecast
- 10.5.2 South Africa Patent Drug Market Forecast
- 10.5.3 Israel Patent Drug Market Forecast
- 10.5.4 Turkey Patent Drug Market Forecast
- 10.5.5 GCC Countries Patent Drug Market Forecast
- 10.6 Global Patent Drug Forecast by Type (2023-2028)
- 10.7 Global Patent Drug Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 Johnson & Johnson
- 11.1.1 Johnson & Johnson Company Information
- 11.1.2 Johnson & Johnson Patent Drug Product Offered
- 11.1.3 Johnson & Johnson Patent Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 Johnson & Johnson Main Business Overview
- 11.1.5 Johnson & Johnson Latest Developments
- 11.2 Novartis
- 11.2.1 Novartis Company Information
- 11.2.2 Novartis Patent Drug Product Offered
- 11.2.3 Novartis Patent Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 Novartis Main Business Overview
- 11.2.5 Novartis Latest Developments
- 11.3 Roche
- 11.3.1 Roche Company Information
- 11.3.2 Roche Patent Drug Product Offered
- 11.3.3 Roche Patent Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 Roche Main Business Overview
- 11.3.5 Roche Latest Developments
- 11.4 AbbVie
- 11.4.1 AbbVie Company Information
- 11.4.2 AbbVie Patent Drug Product Offered
- 11.4.3 AbbVie Patent Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 AbbVie Main Business Overview
- 11.4.5 AbbVie Latest Developments
- 11.5 Merck & Co.
- 11.5.1 Merck & Co. Company Information
- 11.5.2 Merck & Co. Patent Drug Product Offered
- 11.5.3 Merck & Co. Patent Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 Merck & Co. Main Business Overview
- 11.5.5 Merck & Co. Latest Developments
- 11.6 Bristol Myers Squibb
- 11.6.1 Bristol Myers Squibb Company Information
- 11.6.2 Bristol Myers Squibb Patent Drug Product Offered
- 11.6.3 Bristol Myers Squibb Patent Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 Bristol Myers Squibb Main Business Overview
- 11.6.5 Bristol Myers Squibb Latest Developments
- 11.7 GlaxoSmithKline
- 11.7.1 GlaxoSmithKline Company Information
- 11.7.2 GlaxoSmithKline Patent Drug Product Offered
- 11.7.3 GlaxoSmithKline Patent Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 GlaxoSmithKline Main Business Overview
- 11.7.5 GlaxoSmithKline Latest Developments
- 11.8 Pfizer
- 11.8.1 Pfizer Company Information
- 11.8.2 Pfizer Patent Drug Product Offered
- 11.8.3 Pfizer Patent Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.8.4 Pfizer Main Business Overview
- 11.8.5 Pfizer Latest Developments
- 11.9 Sanofi
- 11.9.1 Sanofi Company Information
- 11.9.2 Sanofi Patent Drug Product Offered
- 11.9.3 Sanofi Patent Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.9.4 Sanofi Main Business Overview
- 11.9.5 Sanofi Latest Developments
- 11.10 Takeda
- 11.10.1 Takeda Company Information
- 11.10.2 Takeda Patent Drug Product Offered
- 11.10.3 Takeda Patent Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.10.4 Takeda Main Business Overview
- 11.10.5 Takeda Latest Developments
- 11.11 AstraZeneca
- 11.11.1 AstraZeneca Company Information
- 11.11.2 AstraZeneca Patent Drug Product Offered
- 11.11.3 AstraZeneca Patent Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.11.4 AstraZeneca Main Business Overview
- 11.11.5 AstraZeneca Latest Developments
- 11.12 Bayer
- 11.12.1 Bayer Company Information
- 11.12.2 Bayer Patent Drug Product Offered
- 11.12.3 Bayer Patent Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.12.4 Bayer Main Business Overview
- 11.12.5 Bayer Latest Developments
- 11.13 Eli Lilly & Co.
- 11.13.1 Eli Lilly & Co. Company Information
- 11.13.2 Eli Lilly & Co. Patent Drug Product Offered
- 11.13.3 Eli Lilly & Co. Patent Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.13.4 Eli Lilly & Co. Main Business Overview
- 11.13.5 Eli Lilly & Co. Latest Developments
- 11.14 Gilead Sciences
- 11.14.1 Gilead Sciences Company Information
- 11.14.2 Gilead Sciences Patent Drug Product Offered
- 11.14.3 Gilead Sciences Patent Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.14.4 Gilead Sciences Main Business Overview
- 11.14.5 Gilead Sciences Latest Developments
- 11.15 Amgen
- 11.15.1 Amgen Company Information
- 11.15.2 Amgen Patent Drug Product Offered
- 11.15.3 Amgen Patent Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.15.4 Amgen Main Business Overview
- 11.15.5 Amgen Latest Developments
- 11.16 Novo Nordisk
- 11.16.1 Novo Nordisk Company Information
- 11.16.2 Novo Nordisk Patent Drug Product Offered
- 11.16.3 Novo Nordisk Patent Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.16.4 Novo Nordisk Main Business Overview
- 11.16.5 Novo Nordisk Latest Developments
- 11.17 Teva
- 11.17.1 Teva Company Information
- 11.17.2 Teva Patent Drug Product Offered
- 11.17.3 Teva Patent Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.17.4 Teva Main Business Overview
- 11.17.5 Teva Latest Developments
- 11.18 Boehringer Ingelheim
- 11.18.1 Boehringer Ingelheim Company Information
- 11.18.2 Boehringer Ingelheim Patent Drug Product Offered
- 11.18.3 Boehringer Ingelheim Patent Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.18.4 Boehringer Ingelheim Main Business Overview
- 11.18.5 Boehringer Ingelheim Latest Developments
- 11.19 Biogen
- 11.19.1 Biogen Company Information
- 11.19.2 Biogen Patent Drug Product Offered
- 11.19.3 Biogen Patent Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.19.4 Biogen Main Business Overview
- 11.19.5 Biogen Latest Developments
- 11.20 Astellas
- 11.20.1 Astellas Company Information
- 11.20.2 Astellas Patent Drug Product Offered
- 11.20.3 Astellas Patent Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.20.4 Astellas Main Business Overview
- 11.20.5 Astellas Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Patent Drug. Industry analysis & Market Report on Patent Drug is a syndicated market report, published as Global Patent Drug Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Patent Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
